Hu et al. (2019) demonstrated that curcumin has the potential to inhibit the cancer stemness property (Oct4, Nanog, and Sox2) and the epithelial to mesenchymal (EMT) transition in luminal A cells. The gene discussed is SOX2; the disease is cancer.